Digital Screening for Atrial Fibrillation to Prevent Stroke

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorMedical University Innsbruck

About this trial

The Austrian Digital Heart Study is a population-based, siteless, randomized, controlled digital trial testing whether a smartphone-based atrial fibrillation screening and management pathway reduces stroke hospitalizations compared with usual care. Adults aged 65 years or older in Austria are randomized to either a digital intervention using the 'Pulskontrolle' app or to usual care. The intervention includes smartphone-camera photoplethysmography for atrial fibrillation screening, confirmatory 7-day ECG patch monitoring in case of suspected atrial fibrillation, and digital education and management support. The primary outcome is hospitalization for stroke of any type within 48 months.

Eligibility criteria

Qualifiers

Age ≥ 65 years

Policyholder in Austria (active unique social insurance number)

Written electronic informed consent

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Smartphone-based digital atrial fibrillation screening and management pathway

Treatment groups

100,060 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Medical University Innsbruck

Lead sponsor

AIT Austrian Institute of Technology GmbH

Collaborator

Medical University of Graz

Collaborator

UMIT Tirol

Collaborator